256 related articles for article (PubMed ID: 8442256)
21. Immunosuppressive protocols at transplantation centers in Turkey.
Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
[No Abstract] [Full Text] [Related]
22. Renal transplantation in older patients with double therapy with optional change to cyclosporine monotherapy: long-term results.
Morales JM; Muñoz MA; Campo C; Andres A; Araque A; Alamo C; Praga M; Ortuño T; Hernandez E; Rodicio JL
Transplant Proc; 1994 Oct; 26(5):2511-2. PubMed ID: 7940770
[No Abstract] [Full Text] [Related]
23. Excellent long-term survival of low-risk, first renal allografts using cyclosporine/azathioprine double therapy.
Faull RJ; Bannister KM; Russ GR; Mathew TH; Clarkson AR
Transplant Proc; 1999; 31(1-2):1155-6. PubMed ID: 10083516
[No Abstract] [Full Text] [Related]
24. Current advantage of FK 506 in cadaveric kidney transplantation.
Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
[No Abstract] [Full Text] [Related]
25. Low incidence of chronic rejection in patients experiencing histological acute rejection without simultaneous impairment in liver function tests.
Farges O; Nocci Kalil A; Sebagh M; Reynes M; Bismuth H
Transplant Proc; 1995 Feb; 27(1):1142-3. PubMed ID: 7878827
[No Abstract] [Full Text] [Related]
26. Chronic rejection of renal allografts with four immunosuppressive regimens.
Isoniemi H; Ahonen J; Krogerus L; Eklund B; Höckerstedt K; Salmela K; Häyry P
Transplant Proc; 1992 Dec; 24(6):2716-7. PubMed ID: 1465912
[No Abstract] [Full Text] [Related]
27. Renal allograft rejection in a patient with the Wiskott-Aldrich syndrome.
Meisels IS; Strom TB; Roy-Chaudhury P; Abrams J; Shapiro ME
Transplantation; 1995 Apr; 59(8):1214-5. PubMed ID: 7732568
[No Abstract] [Full Text] [Related]
28. Kidney transplantations with HBsAg+ donors.
Bedrossian J; Akposso K; Metivier F; Moal MC; Pruna A; Idatte JM
Transplant Proc; 1993 Feb; 25(1 Pt 2):1481-2. PubMed ID: 8442160
[No Abstract] [Full Text] [Related]
29. Cyclosporine monotherapy versus OKT3 and cyclosporine versus prednisone and cyclosporine as induction therapy in older renal transplant patients: a multicenter randomized study. Spanish Monotherapy Study Group.
Transplant Proc; 1994 Oct; 26(5):2522-4. PubMed ID: 7940775
[No Abstract] [Full Text] [Related]
30. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival.
Hariharan S; Alexander JW; Schroeder TJ; First MR
Clin Transplant; 1996 Dec; 10(6 Pt 1):538-41. PubMed ID: 8996775
[TBL] [Abstract][Full Text] [Related]
31. Donor-specific transfusion in living related and unrelated donor kidney transplantation: minimal sensitization and excellent graft outcome.
Kong JM; Jeong JH; Kang JK; Seong IG; Kim BC
Transplant Proc; 1995 Feb; 27(1):1036-7. PubMed ID: 7878792
[No Abstract] [Full Text] [Related]
32. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
Scott-Douglas N; Zimmerman D; Klassen J
Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
[No Abstract] [Full Text] [Related]
33. Evaluation of the Banff criteria for the histological diagnosis of rejection in renal allograft biopsies.
Dooper MM; Hoitsma AJ; Koene RA; Bogman MJ
Transplant Proc; 1995 Feb; 27(1):1005-6. PubMed ID: 7878778
[No Abstract] [Full Text] [Related]
34. The effect of donor age on kidney graft function and on histopathological findings.
Isoniemi H; von Willebrand E; Krogerus L; Taskinen E; Ahonen J; Häyry P
Transplant Proc; 1992 Feb; 24(1):328-9. PubMed ID: 1539296
[No Abstract] [Full Text] [Related]
35. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
[No Abstract] [Full Text] [Related]
36. Increased incidence of rejection in patients with delayed graft function.
Howard RJ; Pfaff WW; Brunson ME; Scornik JC; Ramos EL; Peterson JC; Fennell RS; Croker BP
Clin Transplant; 1994 Dec; 8(6):527-31. PubMed ID: 7865914
[TBL] [Abstract][Full Text] [Related]
37. Triple drug maintenance therapy in renal transplantation.
Pallardó LM; Sánchez J; Hernandez M; Górriz JL; Sánchez P; Beneyto I; Rochera A
Transplant Proc; 1992 Feb; 24(1):58-9. PubMed ID: 1539343
[No Abstract] [Full Text] [Related]
38. Predictors of improved outcome in second pediatric renal transplant recipients.
Moss A; Almond PS; Matas AJ; Gillingham K; Najarian JS
Transplant Proc; 1993 Feb; 25(1 Pt 1):597. PubMed ID: 8438429
[No Abstract] [Full Text] [Related]
39. Long-term improvement of chronic renal graft dysfunction in cyclosporine-treated patients by addition of azathioprine and reduction of cyclosporine.
Kliem V; Repp H; Frei U
Transplant Proc; 1994 Oct; 26(5):2553-5. PubMed ID: 7940788
[No Abstract] [Full Text] [Related]
40. Renal transplantation in cyclosporine-treated patients over age 50.
Riera L; Serón D; Castelao AM; Griñó JM; Franco E; Bover J; Vigués L; Alsina J; Serrallach N
Transplant Proc; 1992 Feb; 24(1):122-3. PubMed ID: 1539204
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]